NDC codes

FDA NDC Directory
Product NDC (as listed)65862-214Labeler and product segments. Claims need a package NDC.
Product NDC at billing width65862-0214Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
65862-214-016586202140165862021401100 CAPSULE in 1 BOTTLE (65862-214-01)Marketed from Jun 6, 2008
65862-214-056586202140565862021405500 CAPSULE in 1 BOTTLE (65862-214-05)Marketed from Jun 6, 2008

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Zaleplon
Generic name (nonproprietary)
zaleplon
Active ingredients
Zaleplon — 5 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Aurobindo Pharma LimitedNDC labeler code 65862
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 078829
Marketing start
Listing expires
DEA schedule
CIV
Other FDA classes
Central Nervous System Depression (Physiologic effect)GABA A Agonists (Mechanism)
Identifiers
Product ID 65862-214_36ab371f-c2fe-4c1d-ad60-801b8f118f4eSPL ID 36ab371f-c2fe-4c1d-ad60-801b8f118f4eSPL set ID e092f3ca-bf44-4568-a72c-3fb2cf5b192bRxCUI 313761, 313762UNII S62U433RMH
Pharmacologic class
gamma-Aminobutyric Acid A Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862021401 followed by a unit qualifier and the quantity

Package 65862-0214-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Zaleplon capsules are indicated for the short-term treatment of insomnia. Zaleplon capsules have been shown to decrease the time to sleep onset for up to 30 days in controlled clinical studies (see Clinical Trials under CLINICAL PHARMACOLOGY ). They have not been shown to increase total sleep time or decrease the number of awakenings. The clinical trials performed in support of efficacy ranged from a single night to 5 weeks in duration. The final formal assessments of sleep latency were performed at the end of treatment.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-214

What is NDC 65862-214?
65862-214 is the product NDC for Zaleplon, Zaleplon 5 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Zaleplon.
What is the active ingredient?
Zaleplon.
Who is the labeler?
Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zaleplon?
18 other product NDCs are listed under this name. See all Zaleplon NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zaleplon NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
ZaleplonZaleplon 10 mg/1CapsuleOralPreferred Pharmaceuticals Inc.68788-872568788-8725-0168788-8725-0268788-8725-03+2 more
ZaleplonZaleplon 5 mg/1CapsuleOralBionpharma Inc.69452-36469452-0364-20
ZaleplonZaleplon 10 mg/1CapsuleOralBionpharma Inc.69452-36569452-0365-20
ZaleplonZaleplon 10 mg/1CapsuleOralBryant Ranch Prepack71335-246871335-2468-0171335-2468-0271335-2468-03+1 more
zaleplonZaleplon 10 mg/1CapsuleOralPreferred Pharmaceuticals Inc.68788-720868788-7208-0168788-7208-0268788-7208-03+2 more
zaleplonZaleplon 5 mg/1CapsuleOralUnichem Pharmaceuticals (USA), Inc.29300-13129300-0131-0129300-0131-0529300-0131-13
zaleplonZaleplon 10 mg/1CapsuleOralUnichem Pharmaceuticals (USA), Inc.29300-13229300-0132-0129300-0132-0529300-0132-10
zaleplonZaleplon 10 mg/1CapsuleOralPD-Rx Pharmaceuticals, Inc.43063-78343063-0783-10
zaleplonZaleplon 10 mg/1CapsuleOralA-S Medication Solutions50090-156450090-1564-0050090-1564-01
zaleplonZaleplon 10 mg/1CapsuleOralBryant Ranch Prepack63629-340563629-3405-0163629-3405-0263629-3405-03+1 more

All 19 Zaleplon NDCs

Other NDCs under ANDA 078829

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078829
ProductStrengthForm · routeLabelerProduct NDC
ZaleplonZaleplon 5 mg/1CapsuleOralPD-Rx Pharmaceuticals, Inc.43063-505
ZaleplonZaleplon 5 mg/1CapsuleOralRising Pharma Holdings, Inc.57237-239
ZaleplonZaleplon 10 mg/1CapsuleOralRising Pharma Holdings, Inc.57237-240
ZaleplonZaleplon 10 mg/1CapsuleOralBryant Ranch Prepack71335-1054

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in